Evidence map›Paper›PMID 30309468›Full record

ArticleJournal of the American College of Cardiology2018

Provider Specialty, Anticoagulation, and Stroke Risk in Patients With Atrial Fibrillation and Cancer.

Wesley T O'Neal, J'Neka S Claxton, Pratik B Sandesara, Richard F MacLehose, Lin Y Chen, Lindsay G S Bengtson, Alanna M Chamberlain, Faye L Norby, Pamela L Lutsey, Alvaro Alonso

Open access · greenAbstract read
In one paragraph

Article in Journal of the American College of Cardiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Atrial fibrillation: stroke prevention.The Lancet regional health. Europe · 2024
    Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Atrial fibrillation in older adults with cancer.Journal of geriatric cardiology : JGC · 2022
    Article
  14. Article
  15. Review
  16. Article
  17. DOACs for stroke prevention in patients with AF and cancer.The British journal of cardiology · 2020
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Wesley T O'NealDepartment of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia. Electronic address: wesley.oneal@emory.edu.
J'Neka S ClaxtonDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia.
Pratik B SandesaraDepartment of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia.
Richard F MacLehoseDivision of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota.
Lin Y ChenCardiovascular Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota.
Lindsay G S BengtsonHealth Economics and Outcomes Research, Life Sciences, Optum, Eden Prairie, Minnesota.
Alanna M ChamberlainDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Faye L NorbyDivision of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota.
Pamela L LutseyDivision of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota.
Alvaro AlonsoDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia.
Emory University · USUniversity of Minnesota · USMayo Clinic in Florida · USOptum (United States) · USUniversity of Minnesota Medical Center · US

Funding

Comparative Effectiveness of Oral Anticoagulants in Atrial FibrillationR01HL122200 · NHLBI · UNIVERSITY OF MINNESOTA · PI ALONSO, ALVARO · 2015 to 2017
$1.2M
Atrial fibrillation treatment in older adultsR21AG058445 · NIA · EMORY UNIVERSITY · PI ALONSO, ALVARO · 2018 to 2019
$441k
The Association between Acute Mental Stress and Electrocardiographic Left Atrial AbnormalitiesF32HL134290 · NHLBI · EMORY UNIVERSITY · PI O'NEAL, WESLEY T · 2016 to 2017
$122k
American Heart Association-American Stroke Association 16EIA26410001NHLBI NIH HHS F32 HL134290NHLBI NIH HHS R01 HL122200NIA NIH HHS R21 AG058445
6 · The paper itself

Abstract

backgroundIt is unknown whether early cardiology involvement shortly after atrial fibrillation (AF) diagnosis is associated with favorable outcomes in AF patients who have cancer.

objectivesThe purpose of this study was to examine the relationship between early cardiology involvement after AF diagnosis in patients with history of cancer.

methodsThis study examined associations of early cardiology involvement with oral anticoagulation use, stroke, and bleeding among nonvalvular AF patients (n = 388,045; mean age 68 ± 15 years; 59% male) with a history of cancer (past or active) from the MarketScan database (2009 to 2014). International Classification of Disease-9th Revision-Clinical Modification codes in any position were used to identify cancer diagnosis prior to AF diagnosis. Provider specialty and filled anticoagulant prescriptions 3 months prior to and 6 months after AF diagnosis were obtained. Poisson regression models were used to compute the probability of an oral anticoagulant prescription fill, and Cox regression was used to estimate the risks of stroke and major bleeding.

resultsA total of 64,016 (17%) AF patients had a history of cancer. Cardiology involvement was less likely to occur among patients with a history of cancer than those without (relative risk [RR]: 0.92 [95% confidence interval (CI): 0.91 to 0.93]). Patients with history of cancer were less likely to fill prescriptions for anticoagulants (RR: 0.89 [95% CI: 0.88 to 0.90]) than those without cancer, and similar results were observed across cancer types. Patients with cancer were more likely to fill prescriptions for anticoagulants (RR: 1.48 [95% CI: 1.45 to 1.52]) if seen by a cardiologist. A reduced risk of stroke (hazard ratio: 0.89 [95% CI: 0.81 to 0.99]) was observed among all cancer patients who were seen by a cardiology provider, without an increased risk of bleeding (hazard ratio: 1.04 [95% CI: 0.95 to 1.13]). Similar results were observed when the analysis was stratified by active versus remote history of cancer.

conclusionsAlthough AF patients with cancer were less likely to see a cardiologist, or fill anticoagulant prescriptions, cardiology involvement was associated with increased anticoagulant prescription fills and favorable AF-related outcomes in AF patients with cancer.

Indexed as

Atrial FibrillationCardiologyNeoplasmsAdministration, OralAgedAnticoagulantsComorbidityFemaleHemorrhageHumansMaleMiddle AgedOutcome and Process Assessment, Health CareRisk AdjustmentRisk FactorsStrokeAnticoagulantsanticoagulationatrial fibrillationprovider

Identifiers

PMID30309468
PMCPMC6512871
OpenAlexW2895163750

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.